{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:46:29Z","timestamp":1794357989648,"version":"4.9.0"},"publisher-location":"Dordrecht","reference-count":102,"publisher":"Springer Netherlands","isbn-type":[{"value":"9781402088308","type":"print"},{"value":"9781402088315","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-1-4020-8831-5_17","type":"book-chapter","created":{"date-parts":[[2008,8,26]],"date-time":"2008-08-26T06:33:46Z","timestamp":1219732426000},"page":"441-467","source":"Crossref","is-referenced-by-count":20,"title":["Glycosphingolipid Disorders of the Brain"],"prefix":"10.1007","author":[{"given":"Stephanie D.","family":"Boomkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry D.","family":"Butters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2337\/db06-1619","volume":"56","author":"J. M. Aerts","year":"2007","unstructured":"Aerts, J. M., Ottenhoff, R., Powlson, A. S., Grefhorst, A., van Eijk, M., Dubbelhuis, P. F., Aten, J., Kuipers, F., Serlie, M. J., Wennekes, T., Sethi, J. K., O'Rahilly, S., and Overkleeft, H. S., Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity, Diabetes 56 (2007) 1341\u20131349.","journal-title":"Diabetes"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1042\/BJ20070748","volume":"409","author":"D. S. Alonzi","year":"2008","unstructured":"Alonzi, D. S., Neville, D. C., Lachmann, R. H., Dwek, R. A., and Butters, T. D., Glucosylated free oligosaccharides are biomarkers of endoplasmic- reticulum alpha-glucosidase inhibition, Biochem J 409 (2008) 571\u2013580.","journal-title":"Biochem J"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","volume":"267","author":"N. Asano","year":"2000","unstructured":"Asano, N., Ishii, S., Kizu, H., Ikeda, K., Yasuda, K., Kato, A., Martin, O. R., and Fan, J. Q., In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives, Eur J Biochem 267 (2000) 4179\u20134186.","journal-title":"Eur J Biochem"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0014-4886(03)00345-5","volume":"184","author":"M. Baudry","year":"2003","unstructured":"Baudry, M., Yao, Y., Simmons, D., Liu, J., and Bi, X., Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia, Exp Neurol 184 (2003) 887\u2013903.","journal-title":"Exp Neurol"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/01.wnl.0000194225.78917.de","volume":"66","author":"B. Bembi","year":"2006","unstructured":"Bembi, B., Marchetti, F., Guerci, V. I., Ciana, G., Addobbati, R., Grasso, D., Barone, R., Cariati, R., Fernandez-Guillen, L., Butters, T., and Pittis, M. G., Substrate reduction therapy in the infantile form of Tay-Sachs disease, Neurology 66 (2006) 278\u2013280.","journal-title":"Neurology"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","volume":"57","author":"R. O. Brady","year":"2006","unstructured":"Brady, R. O., Enzyme replacement for lysosomal diseases, Annu Rev Med 57 (2006) 283\u2013296.","journal-title":"Annu Rev Med"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cbpa.2007.05.035","volume":"11","author":"T. D. Butters","year":"2007a","unstructured":"Butters, T. D., Gaucher disease, Curr Opin Chem Biol 11 (2007a) 412\u2013418.","journal-title":"Curr Opin Chem Biol"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1517\/14656566.8.4.427","volume":"8","author":"T. D. Butters","year":"2007b","unstructured":"Butters, T. D., Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders, Expert Opin Pharmacother 8 (2007b) 427\u2013435.","journal-title":"Expert Opin Pharmacother"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","volume":"15","author":"T. D. Butters","year":"2005","unstructured":"Butters, T. D., Dwek, R. A., and Platt, F. M., Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses, Glycobiology 15 (2005) 43R\u201352R.","journal-title":"Glycobiology"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"10373","DOI":"10.1073\/pnas.0603765103","volume":"103","author":"M. B. Cachon-Gonzalez","year":"2006","unstructured":"Cachon-Gonzalez, M. B., Wang, S. Z., Lynch, A., Ziegler, R., Cheng, S. H., and Cox, T. M., Effective gene therapy in an authentic model of Tay-Sachs-related diseases, Proc Natl Acad Sci USA 103 (2006) 10373\u201310378.","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s10545-007-0630-y","volume":"30","author":"Y. H. Chien","year":"2007","unstructured":"Chien, Y. H., Lee, N. C., Tsai, L. K., Huang, A. C., Peng, S. F., Chen, S. J., and Hwu, W. L., Treatment of Niemann-Pick disease type C in two children with miglustat: initial responses and maintenance of effects over 1 year, J Inherit Metab Dis 30 (2007) 826.","journal-title":"J Inherit Metab Dis"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/cbic.200600217","volume":"7","author":"P. Compain","year":"2006","unstructured":"Compain, P., Martin, O. R., Boucheron, C., Godin, G., Yu, L., Ikeda, K., and Asano, N., Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher's disease, Chembiochem 7 (2006) 1356\u20131359.","journal-title":"Chembiochem"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000112332","volume":"6","author":"E. Conzelmann","year":"1983","unstructured":"Conzelmann, E., and Sandhoff, K., Partial enzyme deficiencies: residual activities and the development of neurological disorders, Dev Neurosci 6 (1983) 58\u201371.","journal-title":"Dev Neurosci"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","volume":"355","author":"T. Cox","year":"2000","unstructured":"Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebicek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., Gow, I., Elstein, D., and Zimran, A., Novel oral treatment of Gaucher's Disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis, Lancet 355 (2000) 1481\u20131485.","journal-title":"Lancet"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1042\/bj0600604","volume":"60","author":"C. Duve De","year":"1955","unstructured":"De Duve, C., Pressman, B. C., Gianetto, R., Wattiaux, R., and Appelmans, F., Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue, Biochem J 60 (1955) 604\u2013617.","journal-title":"Biochem J"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/abbi.2001.2320","volume":"389","author":"T. Dumonceaux","year":"2001","unstructured":"Dumonceaux, T., and Carlsen, S. A., Isogloboside biosynthesis in metastatic R3230AC cells results from a decreased GM3 synthase activity, Arch Biochem Biophys 389 (2001) 187\u2013194.","journal-title":"Arch Biochem Biophys"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1182\/blood-2007-02-075960","volume":"110","author":"D. Elstein","year":"2007","unstructured":"Elstein, D., Dweck, A., Attias, D., Hadas-Halpern, I., Zevin, S., Altarescu, G., Aerts, J. F., van Weely, S., and Zimran, A., Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement, Blood 110 (2007) 2296\u20132301.","journal-title":"Blood"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","volume":"27","author":"D. Elstein","year":"2004","unstructured":"Elstein, D., Hollak, C., Aerts, J. M., van Weely, S., Maas, M., Cox, T. M., Lachmann, R. H., Hrebicek, M., Platt, F. M., Butters, T. D., Dwek, R. A., and Zimran, A., Sustained therapeutic effects of oral miglustat (Zavesca, N -butyldeoxynojirimycin, OGT 918) in type I Gaucher disease, J Inherit Metab Dis 27 (2004) 757\u2013766.","journal-title":"J Inherit Metab Dis"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","volume":"24","author":"J. Q. Fan","year":"2003","unstructured":"Fan, J. Q., A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity, Trends Pharmacol Sci 24 (2003) 355\u2013360.","journal-title":"Trends Pharmacol Sci"},{"key":"17_CR20","first-page":"97","volume-title":"Gaucher disease","author":"A. H. Futerman","year":"2007","unstructured":"Futerman, A. H., Cellular pathology in Gaucher disease. In Gaucher disease (A. H. Futerman, and A. Zimran, Eds.), Taylor and Francis Group, Boca Raton, 2007, pp. 97\u2013108"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nrm1423","volume":"5","author":"A. H. Futerman","year":"2004","unstructured":"Futerman, A. H., and van Meer, G., The cell biology of lysosomal storage disorders, Nat Rev Mol Cell Biol 5 (2004) 554\u2013565.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0306-4522(01)00517-6","volume":"109","author":"D. C. German","year":"2002","unstructured":"German, D. C., Liang, C. L., Song, T., Yazdani, U., Xie, C., and Dietschy, J. M., Neurodegeneration in the Niemann-Pick C mouse: glial involvement, Neuroscience 109 (2002) 437\u2013450.","journal-title":"Neuroscience"},{"key":"17_CR23","doi-asserted-by":"crossref","unstructured":"Ghauharali-van der Vlugt, K., Langeveld, M., Poppema, A., Kuiper, S., Hollak, C. E., Aerts, J. M., and Groener, J. E., Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease, Clin Chim Acta (2007) in press","DOI":"10.1016\/j.cca.2007.12.001"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/glycob\/8.9.885","volume":"8","author":"B. K. Gillard","year":"1998","unstructured":"Gillard, B. K., Clement, R. G., and Marcus, D. M., Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways, Glycobiology 8 (1998) 885\u2013890.","journal-title":"Glycobiology"},{"key":"17_CR25","first-page":"703","volume":"91","author":"P. Giraldo","year":"2006","unstructured":"Giraldo, P., Latre, P., Alfonso, P., Acedo, A., Alonso, D., Barez, A., Corrales, A., Franco, R., Roldan, V., Serrano, S., and Pocovi, M., Short-term effect of miglustat in every day clinical use in treatment-naive or previously treated patients with type 1 Gaucher's disease, Haematologica 91 (2006) 703\u2013706.","journal-title":"Haematologica"},{"key":"17_CR26","first-page":"2839","volume-title":"The Metabolic Bases of Inherited Disease","author":"R. A. Gravel","year":"1995","unstructured":"Gravel, R. A., Clarke, J. T. R., Kaback, M. M., Mahuran, D., Sandhoff, K., and Suzuki, K., The GM2 Gangliosidoses, 7 ed. In The Metabolic Bases of Inherited Disease (C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, Eds.), Vol. II, McGraw-Hill, New York, 1995, pp. 2839\u20132879","edition":"7"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/hmg\/7.5.831","volume":"7","author":"J. Guidotti","year":"1998","unstructured":"Guidotti, J., Akli, S., Castelnau-Ptakhine, L., Kahn, A., and Poenaru, L., Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells, Hum Mol Genet 7 (1998) 831\u2013838.","journal-title":"Hum Mol Genet"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ymgme.2007.08.001","volume":"92","author":"L. K. Hein","year":"2007","unstructured":"Hein, L. K., Meikle, P. J., Hopwood, J. J., and Fuller, M., Secondary sphingolipid accumulation in a macrophage model of Gaucher disease, Mol Genet Metab 92 (2007) 336\u2013345.","journal-title":"Mol Genet Metab"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/bcmd.2002.0497","volume":"28","author":"R. Heitner","year":"2002","unstructured":"Heitner, R., Elstein, D., Aerts, J., van Weely, S., and Zimran, A., Low-dose N-butyldeoxynojirimycin (OGT918) for type I Gaucher disease, Blood Cells Mol Dis 28 (2002) 127\u2013133.","journal-title":"Blood Cells Mol Dis"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1074\/jbc.M105457200","volume":"277","author":"S. T. Hepbildikler","year":"2002","unstructured":"Hepbildikler, S. T., Sandhoff, R., Kolzer, M., Proia, R. L., and Sandhoff, K., Physiological substrates for human lysosomal beta -hexosaminidase S, J Biol Chem 277 (2002) 2562\u20132572.","journal-title":"J Biol Chem"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00227765","volume":"85","author":"Y. Higashi","year":"1993","unstructured":"Higashi, Y., Murayama, S., Pentchev, P. G., and Suzuki, K., Cerebellar degeneration in the Niemann-Pick type C mouse, Acta Neuropathol 85 (1993) 175\u2013184.","journal-title":"Acta Neuropathol"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1021\/bi9524575","volume":"35","author":"Y. Hou","year":"1996","unstructured":"Hou, Y., Tse, R., and Mahuran, D. J., Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A, Biochemistry 35 (1996) 3963\u20133969.","journal-title":"Biochemistry"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/hmg\/6.11.1879","volume":"6","author":"J. Q. Huang","year":"1997","unstructured":"Huang, J. Q., Trasler, J. M., Igdoura, S., Michaud, J., Hanal, N., and Gravel, R. A., Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases, Hum Mol Genet 6 (1997) 1879\u20131885.","journal-title":"Hum Mol Genet"},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-2990.2002.00422.x","volume":"28","author":"M. Jeyakumar","year":"2002","unstructured":"Jeyakumar, M., Butters, T. D., Dwek, R. A., and Platt, F. M., Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis, Neuropathol Appl Neurobiol 28 (2002) 343\u2013357.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","volume":"96","author":"M. Jeyakumar","year":"1999","unstructured":"Jeyakumar, M., Butters, T. D., CortinaBorja, M., Hunnam, V., Proia, R. L., Perry, V. H., Dwek, R. A., and Platt, F. M., Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin, Proc Nat Acad Sci USA 96 (1999) 6388\u20136393.","journal-title":"Proc Nat Acad Sci USA"},{"key":"17_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1182\/blood.V97.1.327","volume":"97","author":"M. Jeyakumar","year":"2001","unstructured":"Jeyakumar, M., Norflus, F., Tifft, C. J., CortinaBorja, M., Butters, T. D., Proia, R. L., Perry, V. H., Dwek, R. A., and Platt, F. M., Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation, Blood 97 (2001) 327\u2013329.","journal-title":"Blood"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/brain\/awg089","volume":"126","author":"M. Jeyakumar","year":"2003","unstructured":"Jeyakumar, M., Thomas, R., Elliot-Smith, E., Smith, D. A., van der Spoel, A. C., d'Azzo, A., Perry, V. H., Butters, T. D., Dwek, R. A., and Platt, F. M., Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis, Brain 126 (2003) 974\u2013987.","journal-title":"Brain"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1023\/A:1005419122018","volume":"21","author":"T. Kolter","year":"1998","unstructured":"Kolter, T., and Sandhoff, K., Glycosphingolipid degradation and animal models of GM2-gangliosidoses, J Inherit Metab Dis 21 (1998) 548\u2013563.","journal-title":"J Inherit Metab Dis"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev.cellbio.21.122303.120013","volume":"21","author":"T. Kolter","year":"2005","unstructured":"Kolter, T., and Sandhoff, K., Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids, Annu Rev Cell Dev Biol 21 (2005) 81\u2013103.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.molbrainres.2004.10.026","volume":"133","author":"S. Kyrkanides","year":"2005","unstructured":"Kyrkanides, S., Miller, J. H., Brouxhon, S. M., Olschowka, J. A., and Federoff, H. J., beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration, Brain Res Mol Brain Res 133 (2005) 286\u2013298.","journal-title":"Brain Res Mol Brain Res"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.nbd.2004.05.002","volume":"16","author":"R. H. Lachmann","year":"2004","unstructured":"Lachmann, R. H., Te Vruchte, D., Lloyd-Evans, E., Reinkensmeier, G., Sillence, D. J., Fernandez-Guillen, L., Dwek, R. A., Butters, T. D., Cox, T. M., and Platt, F. M., Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C, Neurobiol Dis 16 (2004) 654\u2013658.","journal-title":"Neurobiol Dis"},{"key":"17_CR42","doi-asserted-by":"crossref","unstructured":"Langeveld, M., Ghauharali, K. J., Sauerwein, H. P., Ackermans, M. T., Groener, J. E., Hollak, C. E., Aerts, H. J., and Serlie, M. J., Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance, J Clin Endocrinol Metab (2007) in press","DOI":"10.1210\/jc.2007-1702"},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF00219337","volume":"88","author":"P. Leinekugel","year":"1992","unstructured":"Leinekugel, P., Michel, S., Conzelmann, E., and Sandhoff, K., Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease, Hum Genet 88 (1992) 513\u2013523.","journal-title":"Hum Genet"},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2353\/ajpath.2007.070052","volume":"171","author":"G. Liao","year":"2007","unstructured":"Liao, G., Yao, Y., Liu, J., Yu, Z., Cheung, S., Xie, A., Liang, X., and Bi, X., Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 \u2013\/\u2013 mouse brain, Am J Pathol 171 (2007) 962\u2013975.","journal-title":"Am J Pathol"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/nbm.984","volume":"18","author":"J. P. Lowe","year":"2005","unstructured":"Lowe, J. P., Stuckey, D. J., Awan, F. R., Jeyakumar, M., Neville, D. C., Platt, F. M., Griffin, J. L., Styles, P., Blamire, A. M., and Sibson, N. R., MRS reveals additional hexose N-acetyl resonances in the brain of a mouse model for Sandhoff disease, NMR Biomed 18 (2005) 517\u2013526.","journal-title":"NMR Biomed"},{"key":"17_CR46","doi-asserted-by":"publisher","first-page":"15912","DOI":"10.1073\/pnas.2536657100","volume":"100","author":"J. Matsuda","year":"2003","unstructured":"Matsuda, J., Suzuki, O., Oshima, A., Yamamoto, Y., Noguchi, A., Takimoto, K., Itoh, M., Matsuzaki, Y., Yasuda, Y., Ogawa, S., Sakata, Y., Nanba, E., Higaki, K., Ogawa, Y., Tominaga, L., Ohno, K., Iwasaki, H., Watanabe, H., Brady, R. O., and Suzuki, Y., Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis, Proc Natl Acad Sci U S A 100 (2003) 15912\u201315917.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"P. J. Meikle","year":"1999","unstructured":"Meikle, P. J., Hopwood, J. J., Clague, A. E., and Carey, W. F., Prevalence of lysosomal storage disorders, J Am Med Assoc 281 (1999) 249\u2013254.","journal-title":"J Am Med Assoc"},{"key":"17_CR48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"R. A. Nixon","year":"2005","unstructured":"Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., and Cuervo, A. M., Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study, J Neuropathol Exp Neurol 64 (2005) 113\u2013122.","journal-title":"J Neuropathol Exp Neurol"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1172\/JCI2127","volume":"101","author":"F. Norflus","year":"1998","unstructured":"Norflus, F., Tifft, C. J., McDonald, M. P., Goldstein, G., Crawley, J. N., Hoffmann, A., Sandhoff, K., Suzuki, K., and Proia, R. L., Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice, J Clin Invest 101 (1998) 1881\u20131888.","journal-title":"J Clin Invest"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2165\/00126839-200607060-00003","volume":"7","author":"G. M. Pastores","year":"2006","unstructured":"Pastores, G. M., and Sathe, S., A chaperone-mediated approach to enzyme enhancement as a therapeutic option for the lysosomal storage disorders, Drugs R D 7 (2006) 339\u2013348.","journal-title":"Drugs R D"},{"key":"17_CR51","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","volume":"27","author":"G. M. Pastores","year":"2005","unstructured":"Pastores, G. M., Barnett, N. L., and Kolodny, E. H., An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment, Clin Ther 27 (2005) 1215\u20131227.","journal-title":"Clin Ther"},{"key":"17_CR52","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.clinthera.2007.08.006","volume":"29","author":"G. M. Pastores","year":"2007","unstructured":"Pastores, G. M., Elstein, D., Hrebicek, M., and Zimran, A., Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies, Clin Ther 29 (2007) 1645\u20131654.","journal-title":"Clin Ther"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","volume":"6","author":"M. C. Patterson","year":"2007","unstructured":"Patterson, M. C., Vecchio, D., Prady, H., Abel, L., and Wraith, J. E., Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study, Lancet Neurol 6 (2007) 765\u2013772.","journal-title":"Lancet Neurol"},{"key":"17_CR54","first-page":"1258","volume":"35","author":"G. M. Petersen","year":"1983","unstructured":"Petersen, G. M., Rotter, J. I., Cantor, R. M., Field, L. L., Greenwald, S., Lim, J. S., Roy, C., Schoenfeld, V., Lowden, J. A., and Kaback, M. M., The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin, Am J Hum Genet 35 (1983) 1258\u20131269.","journal-title":"Am J Hum Genet"},{"key":"17_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/5.1.1","volume":"5","author":"D. Phaneuf","year":"1996","unstructured":"Phaneuf, D., Wakamatsu, N., Huang, J. Q., Borowski, A., Peterson, A. C., Fortunato, S. R., Ritter, G., Igdoura, S. A., Morales, C. R., Benoit, G., Akerman, B. R., Leclerc, D., Hanai, N., Marth, J. D., Trasler, J. M., and Gravel, R. A., Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases, Hum Mol Genet 5 (1996) 1\u201314.","journal-title":"Hum Mol Genet"},{"key":"17_CR56","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","volume":"269","author":"F. M. Platt","year":"1994","unstructured":"Platt, F. M., Neises, G. R., Dwek, R. A., and Butters, T. D., N-Butyldeoxynojirimycin Is a Novel Inhibitor of Glycolipid Biosynthesis, J Biol Chem 269 (1994) 8362\u20138365.","journal-title":"J Biol Chem"},{"key":"17_CR57","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.276.5311.428","volume":"276","author":"F. M. Platt","year":"1997","unstructured":"Platt, F. M., Neises, G. R., Reinkensmeier, G., Townsend, M. J., Perry, V. H., Proia, R. L., Winchester, B., Dwek, R. A., and Butters, T. D., Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin, Science 276 (1997) 428\u2013431.","journal-title":"Science"},{"key":"17_CR58","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1098\/rstb.2003.1268","volume":"358","author":"R. L. Proia","year":"2003","unstructured":"Proia, R. L., Glycosphingolipid functions: insights from engineered mouse models, Phil Trans R Soc Lond B 358 (2003) 879\u2013883.","journal-title":"Phil Trans R Soc Lond B"},{"key":"17_CR59","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/ng1104-1147","volume":"36","author":"R. L. Proia","year":"2004","unstructured":"Proia, R. L., Gangliosides help stabilize the brain, Nat Genet 36 (2004) 1147\u20131148.","journal-title":"Nat Genet"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","volume":"131","author":"D. Reczek","year":"2007","unstructured":"Reczek, D., Schwake, M., Schroder, J., Hughes, H., Blanz, J., Jin, X., Brondyk, W., Van Patten, S., Edmunds, T., and Saftig, P., LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase, Cell 131 (2007) 770\u2013783.","journal-title":"Cell"},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","volume":"14","author":"I. Ron","year":"2005","unstructured":"Ron, I., and Horowitz, M., ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity, Hum Mol Genet 14 (2005) 2387\u20132398.","journal-title":"Hum Mol Genet"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"27310","DOI":"10.1074\/jbc.M502775200","volume":"280","author":"R. Sandhoff","year":"2005","unstructured":"Sandhoff, R., Geyer, R., Jennemann, R., Paret, C., Kiss, E., Yamashita, T., Gorgas, K., Sijmonsma, T. P., Iwamori, M., Finaz, C., Proia, R. L., Wiegandt, H., and Grone, H. J., Novel class of glycosphingolipids involved in male fertility, J Biol Chem 280 (2005) 27310\u201327318.","journal-title":"J Biol Chem"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng1095-170","volume":"11","author":"K. Sango","year":"1995","unstructured":"Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., and Proia, R. L., Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism, Nat Genet 11 (1995) 170\u2013176.","journal-title":"Nat Genet"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/ng1196-348","volume":"14","author":"K. Sango","year":"1996","unstructured":"Sango, K., McDonald, M. P., Crawley, J. N., Mack, M. L., Tifft, C. J., Skop, E., Starr, C. M., Hoffmann, A., Sandhoff, K., Suzuki, K., and Proia, R. L., Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis, Nat Genet 14 (1996) 348\u2013352.","journal-title":"Nat Genet"},{"key":"17_CR65","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1182\/blood-2005-03-1189","volume":"106","author":"R. Sano","year":"2005a","unstructured":"Sano, R., Tessitore, A., Ingrassia, A., and d'Azzo, A., Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology, Blood 106 (2005a) 2259\u20132268.","journal-title":"Blood"},{"key":"17_CR66","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cccn.2004.11.035","volume":"354","author":"R. Sano","year":"2005b","unstructured":"Sano, R., Trindade, V. M., Tessitore, A., d'Azzo, A., Vieira, M. B., Giugliani, R., and Coelho, J. C., G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis, Clin Chim Acta 354 (2005b) 131\u2013139.","journal-title":"Clin Chim Acta"},{"key":"17_CR67","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","volume":"12","author":"A. R. Sawkar","year":"2005","unstructured":"Sawkar, A. R., Adamski-Werner, S. L., Cheng, W. C., Wong, C. H., Beutler, E., Zimmer, K. P., and Kelly, J. W., Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles, Chem Biol 12 (2005) 1235\u20131244.","journal-title":"Chem Biol"},{"key":"17_CR68","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1023\/B:BOLI.0000042959.44318.7c","volume":"27","author":"U. H. Schueler","year":"2004","unstructured":"Schueler, U. H., Kolter, T., Kaneski, C. R., Zirzow, G. C., Sandhoff, K., and Brady, R. O., Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease, J Inherit Metab Dis 27 (2004) 649\u2013658.","journal-title":"J Inherit Metab Dis"},{"key":"17_CR69","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1681\/ASN.2005040383","volume":"16","author":"L. Shu","year":"2005","unstructured":"Shu, L., Murphy, H. S., Cooling, L., and Shayman, J. A., An in vitro model of Fabry disease, J Am Soc Nephrol 16 (2005) 2636\u20132645.","journal-title":"J Am Soc Nephrol"},{"key":"17_CR70","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ng1460","volume":"36","author":"M. A. Simpson","year":"2004","unstructured":"Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M. A., Dwek, R. A., Butters, T. D., Platt, F. M., and Crosby, A. H., Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase, Nat Genet 36 (2004) 1225\u20131229.","journal-title":"Nat Genet"},{"key":"17_CR71","doi-asserted-by":"publisher","first-page":"13813","DOI":"10.1073\/pnas.0605928103","volume":"103","author":"R. A. Steet","year":"2006","unstructured":"Steet, R. A., Chung, S., Wustman, B., Powe, A., Do, H., and Kornfeld, S. A., The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms, Proc Natl Acad Sci U S A 103 (2006) 13813\u201313818.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR72","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1086\/320599","volume":"68","author":"X. Sun","year":"2001","unstructured":"Sun, X., Marks, D. L., Park, W. D., Wheatley, C. L., Puri, V., O'Brien, J. F., Kraft, D. L., Lundquist, P. A., Patterson, M. C., Pagano, R. E., and Snow, K., Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1, Am J Hum Genet 68 (2001) 1361\u20131372.","journal-title":"Am J Hum Genet"},{"key":"17_CR73","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10545-006-0287-y","volume":"29","author":"Y. Suzuki","year":"2006","unstructured":"Suzuki, Y., beta-Galactosidase deficiency: An approach to chaperone therapy, J Inherit Metab Dis 29 (2006) 471\u2013476.","journal-title":"J Inherit Metab Dis"},{"key":"17_CR74","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/jnen\/63.6.660","volume":"63","author":"S. Takikita","year":"2004","unstructured":"Takikita, S., Fukuda, T., Mohri, I., Yagi, T., and Suzuki, K., Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse, J Neuropathol Exp Neurol 63 (2004) 660\u2013673.","journal-title":"J Neuropathol Exp Neurol"},{"key":"17_CR75","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molcel.2004.08.029","volume":"15","author":"A. Tessitore","year":"2004","unstructured":"Tessitore, A., del, P. M. M., Sano, R., Ma, Y., Mann, L., Ingrassia, A., Laywell, E. D., Steindler, D. A., Hendershot, L. M., and d'Azzo, A., GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis, Mol Cell 15 (2004) 753\u2013766.","journal-title":"Mol Cell"},{"key":"17_CR76","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0387-7604(01)00216-9","volume":"23","author":"L. Tominaga","year":"2001","unstructured":"Tominaga, L., Ogawa, Y., Taniguchi, M., Ohno, K., Matsuda, J., Oshima, A., Suzuki, Y., and Nanba, E., Galactonojirimycin derivatives restore mutant human beta-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse, Brain Develop 23 (2001) 284\u2013287.","journal-title":"Brain Develop"},{"key":"17_CR77","doi-asserted-by":"publisher","first-page":"13478","DOI":"10.1074\/jbc.M308523200","volume":"279","author":"M. B. Tropak","year":"2004","unstructured":"Tropak, M. B., Reid, S. P., Guiral, M., Withers, S. G., and Mahuran, D., Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients, J Biol Chem 279 (2004) 13478\u201313487.","journal-title":"J Biol Chem"},{"key":"17_CR78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.chembiol.2006.12.006","volume":"14","author":"M. B. Tropak","year":"2007","unstructured":"Tropak, M. B., Blanchard, J. E., Withers, S. G., Brown, E. D., and Mahuran, D., High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones, Chem Biol 14 (2007) 153\u2013164.","journal-title":"Chem Biol"},{"key":"17_CR79","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1471-4159.2005.02986.x","volume":"92","author":"D. Tsuji","year":"2005","unstructured":"Tsuji, D., Kuroki, A., Ishibashi, Y., Itakura, T., Kuwahara, J., Yamanaka, S., and Itoh, K., Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates, J Neurochem 92 (2005) 1497\u20131507.","journal-title":"J Neurochem"},{"key":"17_CR80","first-page":"E1099","volume":"274","author":"S. D. Turley","year":"1998","unstructured":"Turley, S. D., Burns, D. K., and Dietschy, J. M., Preferential utilization of newly synthesized cholesterol for brain growth in neonatal lambs, Am J Physiol 274 (1998) E1099\u20131105.","journal-title":"Am J Physiol"},{"key":"17_CR81","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1590\/S0100-879X2004000600001","volume":"37","author":"J. C. Tutor","year":"2004","unstructured":"Tutor, J. C., Biochemical characterization of the GM2 gangliosidosis B1 variant, Braz J Med Biol Res 37 (2004) 777\u2013783.","journal-title":"Braz J Med Biol Res"},{"key":"17_CR82","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","volume":"72","author":"A. Tylki-Szymanska","year":"2007","unstructured":"Tylki-Szymanska, A., Czartoryska, B., Vanier, M. T., Poorthuis, B. J., Groener, J. A., Lugowska, A., Millat, G., Vaccaro, A. M., and Jurkiewicz, E., Non-neuronopathic Gaucher disease due to saposin C deficiency, Clin Genet 72 (2007) 538\u2013542.","journal-title":"Clin Genet"},{"key":"17_CR83","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","volume":"1772","author":"M. J. Breemen van","year":"2007","unstructured":"van Breemen, M. J., de Fost, M., Voerman, J. S., Laman, J. D., Boot, R. G., Maas, M., Hollak, C. E., Aerts, J. M., and Rezaee, F., Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease, Biochim Biophys Acta 1772 (2007) 788\u2013796.","journal-title":"Biochim Biophys Acta"},{"key":"17_CR84","doi-asserted-by":"publisher","first-page":"25855","DOI":"10.1074\/jbc.R200010200","volume":"277","author":"G. Meer van","year":"2002","unstructured":"van Meer, G., and Lisman, Q., Sphingolipid transport: rafts and translocators, J Biol Chem 277 (2002) 25855\u201325858.","journal-title":"J Biol Chem"},{"key":"17_CR85","doi-asserted-by":"publisher","first-page":"14777","DOI":"10.1073\/pnas.0506892102","volume":"102","author":"C. Vogler","year":"2005","unstructured":"Vogler, C., Levy, B., Grubb, J. H., Galvin, N., Tan, Y., Kakkis, E., Pavloff, N., and Sly, W. S., Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII, Proc Natl Acad Sci U S A 102 (2005) 14777\u201314782.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR86","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","volume":"97","author":"R. Wada","year":"2000","unstructured":"Wada, R., Tifft, C. J., and Proia, R. L., Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation, Proc Natl Acad Sci U S A 97 (2000) 10954\u201310959.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR87","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","volume":"15","author":"S. U. Walkley","year":"2004","unstructured":"Walkley, S. U., Secondary accumulation of gangliosides in lysosomal storage disorders, Semin Cell Dev Biol 15 (2004) 433\u2013444.","journal-title":"Semin Cell Dev Biol"},{"key":"17_CR88","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/S0021-9258(18)88956-6","volume":"260","author":"T. G. Warner","year":"1985","unstructured":"Warner, T. G., deKremer, R. D., Sjoberg, E. R., and Mock, A. K., Characterization and analysis of branched-chain N-acetylglucosaminyl oligosaccharides accumulating in Sandhoff disease tissue. Evidence that biantennary bisected oligosaccharide side chains of glycoproteins are abundant substrates for lysosomes, J Biol Chem 260 (1985) 6194\u20136199.","journal-title":"J Biol Chem"},{"key":"17_CR89","doi-asserted-by":"publisher","first-page":"12685","DOI":"10.1074\/jbc.M007970200","volume":"276","author":"N. Werth","year":"2001","unstructured":"Werth, N., Schuette, C. G., Wilkening, G., Lemm, T., and Sandhoff, K., Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids, J Biol Chem 276 (2001) 12685\u201312690.","journal-title":"J Biol Chem"},{"key":"17_CR90","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1093\/glycob\/cwi041","volume":"15","author":"B. Winchester","year":"2005","unstructured":"Winchester, B., Lysosomal metabolism of glycoproteins, Glycobiology 15 (2005) 1R\u201315R.","journal-title":"Glycobiology"},{"key":"17_CR91","first-page":"530","volume":"30","author":"E. J. Winsor","year":"1978","unstructured":"Winsor, E. J., and Welch, J. P., Genetic and demographic aspects of Nova Scotia Niemann-Pick disease (type D), Am J Hum Genet 30 (1978) 530\u2013538.","journal-title":"Am J Hum Genet"},{"key":"17_CR92","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0021-9258(19)42862-7","volume":"249","author":"L. S. Wolfe","year":"1974","unstructured":"Wolfe, L. S., Senior, R. G., and Ng-Ying-Kin, N. M., The structures of oligosaccharides accumulating in the liver of G-M1-gangliosidosis, type I, J Biol Chem 249 (1974) 1828\u20131838.","journal-title":"J Biol Chem"},{"key":"17_CR93","doi-asserted-by":"publisher","first-page":"8425","DOI":"10.1073\/pnas.0400625101","volume":"101","author":"Y. P. Wu","year":"2004","unstructured":"Wu, Y. P., and Proia, R. L., Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice, Proc Natl Acad Sci USA 101 (2004) 8425\u20138430.","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1096\/fj.04-2375com","volume":"19","author":"G. H. Yam","year":"2005","unstructured":"Yam, G. H., Zuber, C., and Roth, J., A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder, FASEB J 19 (2005) 12\u201318.","journal-title":"FASEB J"},{"key":"17_CR95","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1073\/pnas.96.16.9142","volume":"96","author":"T. Yamashita","year":"1999","unstructured":"Yamashita, T., Wada, R., Sasaki, T., Deng, C. X., Bierfreund, U., Sandhoff, K., and Proia, R. L., A vital role for glycosphingolipid synthesis during development and differentiation, Proc Natl Acad Sci USA 96 (1999) 9142\u20139147.","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR96","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1073\/pnas.0407785102","volume":"102","author":"T. Yamashita","year":"2005","unstructured":"Yamashita, T., Wu, Y. P., Sandhoff, R., Werth, N., Mizukami, H., Ellis, J. M., Dupree, J. L., Geyer, R., Sandhoff, K., and Proia, R. L., Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions, Proc Natl Acad Sci USA 102 (2005) 2725\u20132730.","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR97","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1073\/pnas.0635898100","volume":"100","author":"T. Yamashita","year":"2003","unstructured":"Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., Sandhoff, R., Sandhoff, K., and Proia, R. L., Enhanced insulin sensitivity in mice lacking ganglioside GM3, Proc Natl Acad Sci USA 100 (2003) 3445\u20133449.","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR98","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1021\/jm060677i","volume":"50","author":"Z. Yu","year":"2007","unstructured":"Yu, Z., Sawkar, A. R., Whalen, L. J., Wong, C. H., and Kelly, J. W., Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention, J Med Chem 50 (2007) 94\u2013100.","journal-title":"J Med Chem"},{"key":"17_CR99","doi-asserted-by":"crossref","first-page":"C1341","DOI":"10.1152\/ajpcell.1992.262.6.C1341","volume":"262","author":"C. B. Zeller","year":"1992","unstructured":"Zeller, C. B., and Marchase, R. B., Gangliosides as modulators of cell function, Am J Physiol 262 (1992) C1341\u20131355.","journal-title":"Am J Physiol"},{"key":"17_CR100","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08035320310021958","volume":"92","author":"M. Zhang","year":"2003","unstructured":"Zhang, M., Sun, M., Dwyer, N. K., Comly, M. E., Patel, S. C., Sundaram, R., Hanover, J. A., and Blanchette-Mackie, E. J., Differential trafficking of the Niemann-Pick C1 and 2 proteins highlights distinct roles in late endocytic lipid trafficking, Acta Paediatr Suppl 92 (2003) 63\u201373.","journal-title":"Acta Paediatr Suppl"},{"key":"17_CR101","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1002\/anie.200502662","volume":"44","author":"X. Zhu","year":"2005","unstructured":"Zhu, X., Sheth, K. A., Li, S., Chang, H. H., and Fan, J. Q., Rational design and synthesis of highly potent beta-glucocerebrosidase inhibitors, Angew Chem Int Ed Engl 44 (2005) 7450\u20137453.","journal-title":"Angew Chem Int Ed Engl"},{"key":"17_CR102","volume-title":"International Practice and Research, 10","author":"A. Zimran","year":"1997","unstructured":"Zimran, A., Gaucher's Disease,Bailliere's Clinical Haematology. International Practice and Research, 10, Bailliere Tindall, London, 1997"}],"container-title":["Subcellular Biochemistry","Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4020-8831-5_17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T09:04:27Z","timestamp":1631696667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4020-8831-5_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9781402088308","9781402088315"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/978-1-4020-8831-5_17","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4020-8831-5","asserted-by":"object"}]},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[]}}